Results
2
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
2 companies
Philogen
Market Cap: €966.3m
A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.
PHIL
€24.30
7D
1.7%
1Y
21.5%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €229.4m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€9.22
-2.3%
7.0%